Patent details
EP2538784 Title: BENZIMIDAZOLE DERIVATIVES USEFUL ANTI-DIABETIC AGENTS
Basic Information
- Publication number:
- EP2538784
- PCT Application Number:
- PCT/US/2011/025585
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP117479105
- PCT Publication Number:
- WO/2011/106273
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- BENZIMIDAZOLE DERIVATIVES USEFUL ANTI-DIABETIC AGENTS
- French Title of Invention:
- DÉRIVÉS DE BENZIMIDAZOLE UTILES COMME AGENTS ANTIDIABÉTIQUES
- German Title of Invention:
- BENZIMIDAZOLDERIVATE ALS ANTIDIABETIKA
- SPC Number:
Dates
- Filing date:
- 21/02/2011
- Grant date:
- 09/09/2015
- EP Publication Date:
- 09/09/2015
- PCT Publication Date:
- 01/09/2011
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 02/01/2013
- EP B1 Publication Date:
- 09/09/2015
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 21/02/2016
- Expiration date:
- 21/02/2031
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 21/02/2011
- Name:
- Merck Sharp & Dohme Corp.
- Address:
- 126 East Lincoln Avenue, Rahway, NJ 07065-0907, United States (US)
Inventor
1
- Name:
- KEKEC Ahmet
- Address:
- United States (US)
2
- Name:
- SEBHAT Iyassu, K.
- Address:
- United States (US)
3
- Name:
- JIANG Jinlong
- Address:
- United States (US)
4
- Name:
- KASSICK Andrew, J.
- Address:
- United States (US)
Priority
- Priority Number:
- 307909 P
- Priority Date:
- 25/02/2010
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61P 3/10;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|